Related Experiment Video
Updated: May 21, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Tumor microRNA-335 expression is associated with poor prognosis in human glioma
Jian Jiang1, Xiaoyang Sun, Weijie Wang
1Department of Neurosurgery, Huaian First Hospital, Nanjing Medical University, Huaian City, 223300, People's Republic of China.
Abstract:
MicroRNA-335 (miR-335), as a transcript of genomic region chromosome 7q32.2, acts as a tumor suppressor or tumor promoter in various human malignancies. Especially, it has been reportedly shown to be an oncogene in human glioma cell line in vitro, but its expression in human glioma tissues is not yet determined. The aim of this study was to investigate the clinical significance of miR-335 expression in glioma. MiR-335 expression in human gliomas and nonneoplastic brain tissues was measured by real-time quantitative RT-PCR assay. The association of miR-335 expression with clinicopathological factors and prognosis of glioma patients was statistically analyzed. The expression level of miR-335 in glioma tissues was significantly higher than that in corresponding nonneoplastic brain tissues (P < 0.001). In addition, high miR-335 expression was significantly associated with a higher WHO grade (P = 0.001). Survival analysis demonstrated that patients with high miR-335 expression tumors had significantly shorter survival times than those with low miR-335 expression tumors (P = 0.01) and that miR-335 was an independent prognostic factor (P = 0.02). Especially, subgroup analyses according to tumor histologic grade revealed that the mean survival time of patients with high grade (III-IV) was significantly worse for high miR-335 expression group than for low miR-335 expression group (P = 0.002), but no significant difference was found for patients with WHO grade I-II (P = 0.16). These results indicated that miR-335 expression was increased in human gliomas and was associated with advanced tumor progression. Furthermore, miR-335 expression was demonstrated for the first time to be an independent marker for predicting the clinical outcome of patients with gliomas.
Insights
MicroRNA-335 (miR-335) is elevated in human gliomas and linked to advanced tumor progression. High miR-335 expression indicates a poorer prognosis and serves as an independent predictor of clinical outcome in glioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-335 (miR-335) has a dual role as a tumor suppressor or promoter.
- Previous in vitro studies suggested miR-335 acts as an oncogene in glioma cell lines.
- Its expression and clinical significance in human glioma tissues remained undetermined.
Purpose of the Study:
- To investigate the clinical significance of miR-335 expression in human glioma tissues.
- To determine the association between miR-335 expression and clinicopathological factors.
- To evaluate miR-335 as a prognostic marker for glioma patients.
Main Methods:
- Real-time quantitative RT-PCR was used to measure miR-335 expression in glioma and nonneoplastic brain tissues.
- Statistical analysis was performed to correlate miR-335 levels with clinicopathological features and patient survival.
- Survival analysis, including subgroup analysis by WHO grade, was conducted.
Main Results:
- miR-335 expression was significantly higher in glioma tissues compared to nonneoplastic brain tissues (P < 0.001).
- High miR-335 expression correlated with higher WHO tumor grade (P = 0.001) and shorter patient survival (P = 0.01).
- miR-335 was identified as an independent prognostic factor (P = 0.02), particularly in high-grade gliomas (P = 0.002).
Conclusions:
- miR-335 expression is upregulated in human gliomas and associated with tumor progression.
- Elevated miR-335 levels predict a worse clinical outcome for glioma patients.
- miR-335 serves as a novel and independent biomarker for predicting glioma patient prognosis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

